MedPath

Red Cell Distribution Width (RDW) as a Prognostic Marker in ICU

Completed
Conditions
Biochemical Marker
Blood Transfusion
Registration Number
NCT02917811
Lead Sponsor
Università degli Studi di Ferrara
Brief Summary

The aim of this study is to verify if high values of RDW are useful prognostic marker for ICU mortality and 90-days mortality. Moreover, we will investigate the prognostic value of RDW in specific subgroup population with some clinical characteristic wich may modify RDW baseline values, i.e. transfused patients or patients with high markers of hemolysis

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Unselected ICU patients
Exclusion Criteria
  • Length of stay in ICU <48 hours
  • Hematological disease
  • Age <18 years

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
90-days mortality90 days
Secondary Outcome Measures
NameTimeMethod
ICU mortality90 days
Length of mechanical ventilation90 days

Trial Locations

Locations (1)

Sant'Anna Hospital

🇮🇹

Ferrara, Italy

Sant'Anna Hospital
🇮🇹Ferrara, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.